Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
Lantheus Holdings (NASDAQ: LNTH) has scheduled its second quarter 2025 earnings conference call and webcast for August 6, 2025, at 8:00 a.m. ET. During this event, the company will discuss its Q2 2025 financial results and provide a business update.
Participants can register for the event at investor.lantheus.com/news-events/calendar-of-events. Registration is recommended 15 minutes before the start time. A replay will be available approximately two hours after the webcast and will remain accessible for at least 30 days.
Lantheus Holdings (NASDAQ: LNTH) ha programmato la conference call e il webcast per la pubblicazione dei risultati del secondo trimestre 2025 il 6 agosto 2025 alle 8:00 ET. Durante l'evento, la società discuterà i risultati finanziari del Q2 2025 e fornirà un aggiornamento sul business.
I partecipanti possono registrarsi all'evento su investor.lantheus.com/news-events/calendar-of-events. Si consiglia la registrazione almeno 15 minuti prima dell'inizio. La registrazione sarà disponibile circa due ore dopo il webcast e resterà accessibile per almeno 30 giorni.
Lantheus Holdings (NASDAQ: LNTH) ha programado su llamada de conferencia y webcast para los resultados del segundo trimestre de 2025 el 6 de agosto de 2025 a las 8:00 a.m. ET. Durante este evento, la empresa discutirá los resultados financieros del Q2 2025 y ofrecerá una actualización del negocio.
Los participantes pueden registrarse para el evento en investor.lantheus.com/news-events/calendar-of-events. Se recomienda registrarse al menos 15 minutos antes del inicio. La repetición estará disponible aproximadamente dos horas después del webcast y permanecerá accesible por al menos 30 días.
Lantheus Holdings (NASDAQ: LNTH)는 2025년 2분기 실적 컨퍼런스 콜 및 웹캐스트를 2025년 8월 6일 오전 8시 ET에 예정했습니다. 이 행사에서 회사는 2025년 2분기 재무 결과를 발표하고 사업 현황을 업데이트할 예정입니다.
참석자는 investor.lantheus.com/news-events/calendar-of-events에서 등록할 수 있습니다. 시작 시간 15분 전까지 등록하는 것이 권장됩니다. 웹캐스트 종료 후 약 2시간 후에 다시보기 서비스가 제공되며, 최소 30일간 이용 가능합니다.
Lantheus Holdings (NASDAQ : LNTH) a programmé sa conférence téléphonique et son webcast pour les résultats du deuxième trimestre 2025 le 6 août 2025 à 8h00 ET. Lors de cet événement, la société présentera ses résultats financiers du T2 2025 et fera un point sur ses activités.
Les participants peuvent s’inscrire à l’événement sur investor.lantheus.com/news-events/calendar-of-events. Il est recommandé de s’inscrire au moins 15 minutes avant le début. Un replay sera disponible environ deux heures après le webcast et restera accessible pendant au moins 30 jours.
Lantheus Holdings (NASDAQ: LNTH) hat seine Telefonkonferenz und Webcast für die Ergebnisse des zweiten Quartals 2025 für den 6. August 2025 um 8:00 Uhr ET angesetzt. Während der Veranstaltung wird das Unternehmen die Finanzergebnisse des Q2 2025 besprechen und ein Geschäftsupdate geben.
Teilnehmer können sich unter investor.lantheus.com/news-events/calendar-of-events registrieren. Eine Registrierung wird empfohlen 15 Minuten vor Beginn. Eine Aufzeichnung wird etwa zwei Stunden nach dem Webcast verfügbar sein und mindestens 30 Tage lang zugänglich bleiben.
- None.
- None.
BEDFORD, Mass., July 23, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, August 6, 2025, to discuss its financial results and provide a business update for the second quarter of 2025.
To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.
A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Switzerland and Sweden, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
